TickerHumNYSE · Healthcare · Medical Devices
Boston Scientific Corporation (BSX)
As of Nov 11, 1:50 PM ET, Boston Scientific (BSX) last traded at $45.45, up 1.67% on the day. Its TickerHum research score is 50/100 (average). It reported revenue of $21.07B for the twelve months ending 2026-09-30, up 8.9% year over year, with a 18.7% operating margin.
Ratings
- Valuation: 81/100 — Strongest input: price / sales (ttm) 3.1x. Weakest: free-cash-flow yield 5.1 %.
- Growth: 63/100 — Strongest input: diluted eps growth (ttm, yoy) +26.7 %. Weakest: revenue growth (ttm, yoy) +8.9 %.
- Profitability: 71/100 — Strongest input: gross margin 69.1 %. Weakest: return on equity 13.6 %.
- Financial health: 40/100 — Strongest input: long-term debt / equity 0.43. Weakest: cash / long-term debt 0.06.
- Momentum: 12/100 — Strongest input: 6-month return -14.4 %. Weakest: 1-year return -56.4 %.
- Attention: 50/100 — Strongest input: headlines in the last 7 days 24. Weakest: volume vs 3-month average 0.4x.
- Risk resilience: 30/100 — Strongest input: annualised volatility (1y) 41.2 %. Weakest: max drawdown (1y) -60.4 %.
- Data confidence: 100/100 — Based on inputs available 100 %, quote age (hours) 0 h, latest financial period age (days) 43 d.
Reported fundamentals
| Metric | Value | Period |
|---|---|---|
| Revenue | $21.07B | TTM ending 2026-09-30 · 10-Q |
| Revenue growth | 8.9% | TTM ending 2026-09-30 · 10-Q |
| Net income | $3.49B | TTM ending 2026-09-30 · 10-Q |
| Diluted EPS | $2.37 | TTM ending 2026-09-30 · 10-Q |
| Gross margin | 69.1% | TTM ending 2026-09-30 · 10-Q |
| Operating margin | 18.7% | TTM ending 2026-09-30 · 10-Q |
| Net margin | 16.6% | TTM ending 2026-09-30 · 10-Q |
| Free cash flow | $3.33B | TTM ending 2026-09-30 · 10-Q |
| Cash | $609M | as of 2026-09-30 · 10-Q |
| Long-term debt | $10.91B | as of 2026-09-30 · 10-Q |
| Debt / equity | 0.43 | as of 2026-09-30 · 10-Q |
Source: SEC EDGAR XBRL company facts (CIK 0000885725).
Comparable companies for Boston Scientific
Selected by industry, business overlap and scale; these are not necessarily direct competitors.
- Boston Scientific vs Medtronic (BSX vs MDT) — Same industry (Medical Devices); market cap 2.0x; shares: cardiology, medical devices
- Boston Scientific vs Edwards Lifesciences (BSX vs EW) — Same industry (Medical Devices); market cap 0.91x; shares: cardiology
- Boston Scientific vs Stryker (BSX vs SYK) — Same industry (Medical Devices); market cap 1.8x; shares: medical devices
- Boston Scientific vs Abbott Laboratories (BSX vs ABT) — Same industry (Medical Devices); market cap 2.9x; shares: medical devices
- Boston Scientific vs Becton, Dickinson and (BSX vs BDX) — Same sector (Healthcare), different industry; market cap 0.88x
Prices: Yahoo Finance (public) — Free public Yahoo Finance data. Prices may be delayed and are for information only.